Resultados de procura - David Drobne

  • Mostrando 1 - 7 Resultados de 7
Limitar resultados
  1. 1
    Oxidative stress-related biomarkers as promising indicators of inflammatory bowel disease activity: A systematic review and meta-analysis

    Oxidative stress-related biomarkers as promising indicators of inflammatory bowel disease activity: A systematic review and meta-analysis por Armando Tratenšek, Igor Locatelli, Iztok Grabnar, David Drobne, Tomaž Vovk

    Publicado 2024
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  2. 2
    Down‐regulation of micro<scp>RNA</scp>s of the <i>miR‐200</i> family and up‐regulation of Snail and Slug in inflammatory bowel diseases — hallmark of epithelial−mesenchymal transition

    Down‐regulation of micro<scp>RNA</scp>s of the <i>miR‐200</i> family and up‐regulation of Snail and Slug in inflammatory bowel diseases — hallmark of epithelial−mesenchymal transit... por Nina Zidar, Emanuela Boštjančič, Miha Jerala, Nika Kojc, David Drobne, Borut Štabuc, Damjan Glavač

    Publicado 2016
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  3. 3
    Early Trough Levels and Antibodies to Infliximab Predict Safety and Success of Reinitiation of Infliximab Therapy

    Early Trough Levels and Antibodies to Infliximab Predict Safety and Success of Reinitiation of Infliximab Therapy por Filip Baert, David Drobne, Ann Gils, Niels Vande Casteele, Scott Hauenstein, Sharat Singh, S. Lockton, Paul Rutgeerts, Séverine Vermeire

    Publicado 2014
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  4. 4
    Intravenous versus subcutaneous delivery of biotherapeutics in IBD: an expert’s and patient’s perspective

    Intravenous versus subcutaneous delivery of biotherapeutics in IBD: an expert’s and patient’s perspective por Laimas Virginijus Jonaitis, Srdjan Marković, Klaudia Farkas, Liana Gheorghe, Željko Krznarić, Riina Salupere, Viktorija Mokricka, Zoya Spassova, Dimo Gatev, Isabella Grosu, Anton Lijović, Olga Mitrović, Mateja Saje, Eszter Schäfer, Viktor Uršič, Tina Roblek, David Drobne

    Publicado 2021
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  5. 5
    Therapeutic drug monitoring of biologics in inflammatory bowel disease: unmet needs and future perspectives

    Therapeutic drug monitoring of biologics in inflammatory bowel disease: unmet needs and future perspectives por Konstantinos Papamichael, Waqqas Afif, David Drobne, Marla C. Dubinsky, Marc Ferrante, Peter M. Irving, Nikolaos Kamperidis, Taku Kobayashi, Paulo Gustavo Kotze, Jo Lambert, Nurulamin M Noor, Xavier Roblin, Giulia Roda, Niels Vande Casteele, Andrés Yarur, Naila Arebi, Silvio Danese, Stéphane Paul, William J. Sandborn, Séverine Vermeire, Adam S. Cheifetz, Laurent Peyrin‐Biroulet

    Publicado 2022
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  6. 6
    Effectiveness of ustekinumab dose escalation in Crohn’s disease patients with insufficient response to standard‐dose subcutaneous maintenance therapy

    Effectiveness of ustekinumab dose escalation in Crohn’s disease patients with insufficient response to standard‐dose subcutaneous maintenance therapy por Uri Kopylov, Jurij Hanžel, Claire Liefferinckx, Davide De Marco, Nicola Imperatore, Nikolas Plevris, Iria Bastón‐Rey, Richard Harris, Marie Truyens, Viktor Domislović, Stephan R. Vavricka, Vince Biemans, Sally Myers, Shaji Sebastian, Shomron Ben–Horin, Yago González Lama, Cyrielle Gilletta, Bar‐Gil Shitrit Ariella, Zuzana Zelinková, Roni Weisshof, Darragh Storan, Eran Zittan, Klaudia Farkas, Tamás Molnár, Denis Franchimont, Anneline Cremer, Waqqas Afif, Fabiana Castiglione, Charlie W. Lees, Manuel Barreiro‐de Acosta, Triana Lobatón, Glen Doherty, Željko Krznarić, Marieke Pierik, Frank Hoentjen, David Drobne

    Publicado 2020
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  7. 7
    Endoscopic Postoperative Recurrence in Crohn’s Disease After Curative Ileocecal Resection with Early Prophylaxis by Anti-TNF, Vedolizumab or Ustekinumab: A Real-World Multicentre European Study

    Endoscopic Postoperative Recurrence in Crohn’s Disease After Curative Ileocecal Resection with Early Prophylaxis by Anti-TNF, Vedolizumab or Ustekinumab: A Real-World Multicentre E... por Henit Yanai, A Kagramanova, O. V. Knyazev, João Sabino, Shana Haenen, Gerassimos J. Mantzaris, Katerina Mountaki, Alessandro Armuzzi, Daniela Pugliese, Federica Furfaro, Gionata Fiorino, David Drobne, Tina Kurent, Sharif Yassin, Nitsan Maharshak, Fabiana Castiglione, Roberto de Sire, Olga Maria Nardone, Klaudia Farkas, Tamás Molnár, Željko Krznarić, Marko Brinar, E. Yu. Chashkova, Moran Livne Margolin, Uri Kopylov, Cristina Bezzio, Ariella Bar‐Gil Shitrit, Milan Lukáš, María Chaparro, Marie Truyens, Stéphane Nancey, Triana Lobatón, Javier P. Gisbert, Simone Saibeni, P Bacsúr, Peter Bossuyt, Julien D. Schulberg, Frank Hoentjen, Chiara Viganò, Andrea Palermo, Joana Torres, Joana Revés, Konstantinos Κarmiris, Magdalini Velegraki, Edoardo Savarino, Panagiotis Markopoulos, Eftychia Tsironi, Pierre Ellul, Cristina Suárez, Roni Weisshof, Dana Ben-Hur, Timna Naftali, Carl Eriksson, Ioannis E. Κoutroubakis, Kalliopi Foteinogiannopoulou, Jimmy K. Limdi, Eleanor Liu, Gerard Surís, Emma Calabrese, Francesca Zorzi, Rafał Filip, Davide Giuseppe Ribaldone, Yifat Snir, Idan Goren, Hagar Banai-Eran, Yelena Broytman, Hadar Amir Barak, Irit Avni‐Biron, Jacob E. Ollech, Iris Dotan, Maya Aharoni Golan

    Publicado 2022
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: